Cargando…
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors
BACKGROUND: The effectiveness of MAPK pathway inhibitors (MAPKi) used to treat patients with BRAF-mutant melanoma is limited by a range of resistance mechanisms, including soluble TNF (solTNF)-mediated NF-kB signaling. solTNF preferentially signals through type-1 TNF receptor (TNFR1), however, it ca...
Autores principales: | Sander, Cindy A., Rush, Elizabeth A., Shi, Jian, Arantes, Lidia M. R. B., Tesi, Raymond J., Ross, Mark A., Calderon, Michael J., Watkins, Simon C., Kirkwood, John M., Ferris, Robert L., Butterfield, Lisa H., Vujanovic, Lazar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310383/ https://www.ncbi.nlm.nih.gov/pubmed/35879777 http://dx.doi.org/10.1186/s12967-022-03538-w |
Ejemplares similares
-
Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands
por: Janjic, Bratislav M., et al.
Publicado: (2022) -
Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
por: Naveh, Hadas Prag, et al.
Publicado: (2013) -
The roles of TNF-α and the soluble TNF receptor I on sleep architecture in OSA
por: Yue, Herbert J., et al.
Publicado: (2009) -
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma
por: Tarhini, Ahmad A, et al.
Publicado: (2014) -
CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)